Q3 2020 13F Holders as of 30 Sep 2020
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share (the "Common Stock")
-
Shares outstanding
-
62,650,155
-
Total 13F shares
-
53,525,011
-
Share change
-
-853,171
-
Total reported value
-
$3,268,922,370
-
Put/Call ratio
-
38%
-
Price per share
-
$61.12
-
Number of holders
-
218
-
Value change
-
-$23,439,447
-
Number of buys
-
102
-
Number of sells
-
98
Institutional Holders of Sage Therapeutics, Inc. - Common Stock, par value $0.0001 per share (the "Common Stock") (SAGE) as of Q3 2020
As of 30 Sep 2020,
Sage Therapeutics, Inc. - Common Stock, par value $0.0001 per share (the "Common Stock") (SAGE) was held by
218 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
53,525,011 shares.
The largest 10 holders included
FMR LLC, VANGUARD GROUP INC, BlackRock Inc., PRICE T ROWE ASSOCIATES INC /MD/, D. E. Shaw & Co., Inc., GREAT POINT PARTNERS LLC, JANUS HENDERSON GROUP PLC, Bellevue Group AG, JPMORGAN CHASE & CO, and Invesco Ltd..
This page lists
220
institutional shareholders reporting positions in this security
for the Q3 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.